Nauka i badania

Rak szyjki macicy

van der Zee J, González González D, van Rhoon GC, van Dijk JD, van Putten WL, Hart AA. Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumours: a prospective, randomised, multicentre trial. Dutch Deep Hyperthermia Group. Lancet. (2000) Apr 1;355(9210):1119-25. DOI: 10.1016/s0140-6736(00)02059-6

Harima Y, Nagata K, Harima K, Ostapenko VV, Tanaka Y, Sawada S. A randomized clinical trial of radiation therapy versus thermoradiotherapy in stage IIIB cervical carcinoma. International Journal of Hyperthermia (2001) Mar-Apr;17(2):97-105.

van der Zee J, González GD. The Dutch Deep Hyperthermia Trial: results in cervical cancer. International Journal of Hyperthermia (2002) Jan-Feb;18(1):1-12.

Vasanthan A, Mitsumori M, Park JH, Zhi-Fan Z, Yu-Bin Z, Oliynychenko P, Tatsuzaki H, Tanaka Y, Hiraoka M. Regional hyperthermia combined with radiotherapy for uterine cervical cancers: a multi-institutional prospective randomized trial of the international atomic energy agency. International Journal of Radiation Oncology ÔÇó Biology ÔÇó Physics. (2005) Jan 1;61(1):145-53. DOI: 10.1016/j.ijrobp.2004.04.057

Franckena M, Stalpers LJ, Koper PC, Wiggenraad RG, Hoogenraad WJ, van Dijk JD, W├írl├ím-Rodenhuis CC, Jobsen JJ, van Rhoon GC, van der Zee J. Long-term improvement in treatment outcome after radiotherapy and hyperthermia in locoregionally advanced cervix cancer: an update of the Dutch Deep Hyperthermia Trial. International Journal of Radiation Oncology ÔÇó Biology ÔÇó Physics. (2008) Mar 15;70(4):1176-82. DOI: 10.1016/j.ijrobp.2007.07.2348

Fatehi D, van der Zee J, de Bruijne M, Franckena M, van Rhoon GC. RF-power and temperature data analysis of 444 patients with primary cervical cancer: deep hyperthermia using the Sigma-60 applicator is reproducible. International Journal of Hyperthermia (2007) Dec;23(8):623-43. DOI: 10.1080/02656730701827557

Harima Y, Nagata K, Harima K, Ostapenko VV, Tanaka Y, Sawada S. A randomized clinical trial of radiation therapy versus thermoradiotherapy in stage IIIB cervical carcinoma. International Journal of Hyperthermia (2001) Mar-Apr;17(2):97-105.

Lutgens L, van der Zee J, Pijls-Johannesma M, De Haas-Kock DFM, Buijsen J, Mastrigt GAPGV, Lammering G, De Ruysscher DKM, Lambin P. Combined use of hyperthermia and radiation therapy for treating locally advanced cervical carcinoma (Review). Cochrane Database Systematic Review  (2010) Jan 20;(1):CD006377. DOI: 10.1002/14651858.CD006377.pub2.

┼Üpiewankiewicz B, Piotrkowicz N, Nalewczy┼äska A, Timorek-Lemieszczuk A. Zastosowanie przedoperacyjnej brachyterapii z hipertermi─ů w leczeniu raka trzonu macicy ÔÇô wst─Öpne wyniki w┼éasne. Current Gynecologic Oncology (2010), 8 (1), p. 21-26

Zolciak-Siwinska A, Piotrkowicz N, Jonska-Gmyrek J, Nicke-Psikuta M, Michalski W, Kawczy┼äska M, Bijok M, Bujko K. HDR brachytherapy combined with interstitial hyperthermia in locally advanced cervical cancer patients initially treated with concomitant radiochemotherapy – a phase III study. Radiotherapy and Oncology (2013) Nov;109(2):194-9. DOI: 10.1016/j.radonc.2013.04.011.

Datta NR, Rogers S, Klingbiel D, G├│mez S, Puric E, Bodis S. Hyperthermia and radiotherapy with or without chemotherapy in locally advanced cervical cancer: a systematic review with conventional and network meta-analyses. International Journal of Hyperthermia (2016 Nov;32(7):809-21. DOI: 10.1080/02656736.2016.1195924.

Harima Y, Ohguri T, Imada H, Sakurai H, Ohno T, Hiraki Y, Tuji K, Tanaka M, Terashima H. A multicentre randomised clinical trial of chemoradiotherapy plus hyperthermia versus chemoradiotherapy alone in patients with locally advanced cervical cancer. International Journal of Hyperthermia (2016 Nov;32(7):801-8. DOI: 10.1080/02656736.2016.1213430.

Ohguri T, Harima Y, Imada H, Sakurai H, Ohno T, Hiraki Y, Tuji K, Tanaka M, Terashima H. Relationships between thermal dose parameters and the efficacy of definitive chemoradiotherapy plus regional hyperthermia in the treatment of locally advanced cervical cancer: data from a multicentre randomised clinical trial. International Journal of Hyperthermia (2018) Jun;34(4):461-468. DOI: 10.1080/02656736.2017.1352105.

HT Systems

ul. Belgradzka 5
02-793 Warszawa

+48 22 300 91 85

info@htsystems.com.pl

logo HT SYSTEMS

NOWOCZESNA
MEDYCYNA W WALCE
Z RAKIEM

Godziny pracy biura:

Poniedzia┼éek - pi─ůtek od 8:00 do 18:00